Hyperthermia enhancement of antibody-complement cytotoxicity for human colon tumor cells. 1981

W A Tompkins, and G V Rama Rao, and P Pantasatos, and C A Cain

HCT-8R human colon tumor cells heated for 60 minutes at 37-44.5 degrees C showed an increased sensitivity to lysis by rabbit anti-HCT-8R antibodies and complement (Ab-C) at the higher temperatures. As compared to the 51Cr release assay, the colony formation (CF) assay was a more sensitive measure of hyperthermia-induced cell damage and sensitization to Ab-C lysis. Also the CF assay was more efficient than the 51Cr assay in detecting effects of low-temperature heating (41.5 degrees C) on Ab-C cytotoxicity. The direct toxicity of heating alone was minimal. Because heating did not influence the pH of the medium, the pH of our assay system did not appear to be factor in the enhanced sensitivity of heated cells to Ab-C cytotoxicity. Significantly smaller amounts of antibodies were capable of lysing heated cells as compared to unheated cells, but heated cells did not bind more antibodies than did unheated cells. This suggests that the hyperthermia effect on the cell occurs at some stage of the lytic event after antibody binding. Hyperthermia treatment at 43.5 degrees C enhanced cytotoxicity by antibodies monospecific to carcinoembryonic antigen, which is expressed on the surface of these cells. Thus hyperthermia may be an effective tool in augmenting specific immune reactions against tumor-associated cell membrane antigens.

UI MeSH Term Description Entries
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000912 Antibodies, Neoplasm Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS. Neoplasm Antibodies,Tumor Antibodies,Antibodies, Tumor
D000937 Antigen-Antibody Reactions The processes triggered by interactions of ANTIBODIES with their ANTIGENS. Antigen Antibody Reactions,Antigen-Antibody Reaction,Reaction, Antigen-Antibody,Reactions, Antigen-Antibody

Related Publications

W A Tompkins, and G V Rama Rao, and P Pantasatos, and C A Cain
January 1995, Immunology letters,
W A Tompkins, and G V Rama Rao, and P Pantasatos, and C A Cain
December 1977, Infection and immunity,
W A Tompkins, and G V Rama Rao, and P Pantasatos, and C A Cain
May 1979, The Journal of clinical investigation,
W A Tompkins, and G V Rama Rao, and P Pantasatos, and C A Cain
August 1978, Journal of immunology (Baltimore, Md. : 1950),
W A Tompkins, and G V Rama Rao, and P Pantasatos, and C A Cain
December 1993, Diseases of the colon and rectum,
W A Tompkins, and G V Rama Rao, and P Pantasatos, and C A Cain
February 1980, Journal of immunology (Baltimore, Md. : 1950),
W A Tompkins, and G V Rama Rao, and P Pantasatos, and C A Cain
March 1981, Cancer research,
W A Tompkins, and G V Rama Rao, and P Pantasatos, and C A Cain
June 1982, Radiation research,
W A Tompkins, and G V Rama Rao, and P Pantasatos, and C A Cain
February 1985, Journal of the National Cancer Institute,
W A Tompkins, and G V Rama Rao, and P Pantasatos, and C A Cain
January 1990, Cancer research,
Copied contents to your clipboard!